glp 1 tri LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Compounded GLP-1s: Why doctors worry

Retatrutide works through many of the same mechanisms as semaglutide and tirzepatide, including reducing appetite, increasing fullness, and slowing gastric emptying

Now, what was originally developed for glucose control has demonstrated decreased gastric emptying, increased satiety, and decreased appetite

When the gut lining becomes compromised, it can lead to a wide range of issues including inflammation, poor digestion, and systemic health disruptions

Should I stop taking my medication if I experience constipation

Schedule your medical weight loss consultation with our Houston doctor at Apex MD Primary Care & Wellness Center today!